For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
This 124-page report provides assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for coagulation testing.
The report also includes strategic assessments of current and emerging suppliers of coagulation instruments and reagents, products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 124 pages